Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Dominique Castagliola
Bruno Ledergerber
Carlo Torti
Ard van Sighem
Daniel Podzamczer
Amanda Mocroft
Maria Dorrucci
Bernard Masquelier
Andrea de Luca
Klaus Jansen
Stephane De Wit
Obel, Niels
Gerd Fätkenheuer
Giota Touloumi
Cristina Mussini
Antonella Castagna
Cristoph Stephan
Frederico Garcia
Robert Zangerle
Xavier Duval
Santiago Pérez-Hoyos
Laurence Meyer
Jade Ghosn
Céline Fabre-Colin
Jesper Kjaer
Genevieve Chene
Dominque Costagliola
Rebecca Lodwick
Andrew Phillips
Pursuing Later Treatment Option II (PLATO II) project team

Limited treatment options have been available for people with HIV who have had virological failure of the three original classes of HIV antiretroviral drugs-so-called triple-class virological failure (TCVF). However, introduction of new drugs and drug classes might have improved outcomes. We aimed to assess trends in virological and clinical outcomes for individuals with TCVF in 2000-09.

Originalsprog	Engelsk
Tidsskrift	Lancet Infectious Diseases
Vol/bind	12
Udgave nummer	2
Sider (fra-til)	119-27
Antal sider	9
ISSN	1473-3099
DOI	https://doi.org/10.1016/S1473-3099(11)70248-1
Status	Udgivet - 2012

ID: 48545359